Search results for TNF alpha Antibody

Anti-TNF alpha antibody [EPR22598-212], Abcam, AB255275

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-TNF alpha antibody [MP6-XT3], Abcam, AB11564

This product should be stored undiluted. Should this product contain a precipitate we recommend microcentrifugation before use.

Anti-TNF alpha antibody [NF-7], Abcam, AB9809

This antibody can be used in two-site immunoassay for the determination of human TNF alpha. It recognizes a different epitope than the monoclonal antibody ab9813 . The two-site immunoassay can be used to determine TNF alpha concentration in the cultures of human peripheral blood mononuclear cells. Can also be used to neutralize TNF alpha cytotoxic activity in vitro. At a concentration of 2.5 μg/ml, antibody ab9809 causes 50% inhibition of TNF alpha mediated cytotoxicity on L929 cells. This product was changed from ascites to tissue culture supernatant on 28/11/2017. Lot numbers higher than GR151594-8 will be from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly. This product was changed from ascites to tissue culture supernatant on 28/11/2017. Lot numbers higher than GR151594-8 will be from tissue culture supernatant. Please note that the dilutions may need to be adjusted accordingly. This antibody can be used in two-site immunoassay for the determination of human TNF alpha. It recognizes a different epitope than the monoclonal antibody ab9813 . The two-site immunoassay can be used to determine TNF alpha concentration in the cultures of human peripheral blood mononuclear cells. Can also be used to neutralize TNF alpha cytotoxic activity in vitro. At a concentration of 2.5 μg/ml, antibody ab9809 causes 50% inhibition of TNF alpha mediated cytotoxicity on L929 cells.

Anti-TNF alpha antibody [P/T2], Abcam, AB9579

Anti-TNF alpha antibody [TNF/1500R], Abcam, AB270264

Anti-TNF alpha antibody [TNFA/1172], Abcam, AB220210

What is this antibody validated in? Anti-TNF alpha antibody [TNFA/1172] (ab220210) is a mouse monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human, Rat samples. Trusted by the scientific community Anti-TNF alpha [TNFA/1172] (ab220210) was first used in a scientific publication in 2017 and has been cited over 30 times in peer-reviewed journals. Other related products We have a range of other formats of antibody clone [TNFA/1172] also available for your convenience: ab220210, Carrier free - ab269772

Anti-TNF alpha antibody [V1q(H8)], Abcam, AB8097

Anti-Dog TNFa/TNF-alpha Antibody (SAA2422), ProteoGenix, ARO-A22862

Anti-Human TNFa/TNF-alpha Antibody (SAA2506), ProteoGenix, ARO-A22950

PE Anti-TNF alpha antibody [EPR21753-109], Abcam, AB322526

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .